Mark McDade insider trades
Open-market stock purchases and sales by Mark McDade, Unknown at Tourmaline Bio, Inc, from SEC Form 4 filings since May 16, 2014.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +48%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 28, 2025 | TRML Tourmaline Bio, Inc | Sold (not open market) | — |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc | Sold (not open market) | — |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc | Sold (not open market) | $189K |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc | Sold (not open market) | $139K |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc | Sold (not open market) | $315K |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc | Sold (not open market) | — |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc | Sold (not open market) | — |
Companies traded
- TRML Tourmaline Bio, Inc: 1 buy, last Oct 28, 2025
- ICVX Icosavax, Inc: 1 buy, last Feb 19, 2024
- TALS Talaris Therapeutics, Inc: other filings, last Jun 13, 2023
- AIMT Aimmune Therapeutics, Inc: 1 buy, last Oct 13, 2020
- DERM Dermira, Inc: other filings, last Feb 20, 2020
- NONE Phillips Edison Grocery Center REIT II, Inc: other filings, last Nov 2, 2018
- N/A Phillips Edison Grocery Center REIT II, Inc: 2 buys, last Aug 7, 2018
- FPRX Five Prime Therapeutics Inc: other filings, last May 10, 2018